Human Papillomavirus (HPV) Vaccine Global Market Report 2024 Global Market Analysis, Trends, Growth, Research And Forecast 2033

The new report published by The Business Research Company, titled Human Papillomavirus (HPV) Vaccine Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the human papillomavirus (hpv) vaccine market size has grown rapidly in recent years. It will grow from $5.12 billion in 2023 to $5.87 billion in 2024 at a compound annual growth rate (CAGR) of 14.5%. The human papillomavirus (hpv) vaccine market size is expected to see rapid growth in the next few years. It will grow to $9.61 billion in 2028 at a compound annual growth rate (CAGR) of 13.1%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=12040&type=smp

Rising Prevalence Of HPV-Related Diseases Sparks Surge In Human Papillomavirus (HPV) Vaccine Market Growth
The increased prevalence of HPV-related diseases is expected to propel the growth of the human papillomavirus (HPV) vaccine market going forward. HPV-related diseases are viral infections that frequently result in warts on the skin or mucous membranes. The HPV vaccination specifically targets the HPV subtypes. The HPV vaccine controls the risk of HPV infection and recurrent diseases. For Instance, in February 2023, according to the National Cancer Institute, a US-based Department of Health and Human Services, around 13,960 American women are anticipated to have an aggressive cervical cancer diagnosis, and 4,310 fatalities from this illness are expected in 2023 in the US. Further, 7.7 per 100,000 women per year new cases of cervical cancer were diagnosed, with an annual death rate of 2.2 per 100,000 females. Therefore, the increased prevalence of HPV-related diseases is driving the growth of the human papillomavirus (HPV) vaccine market.

Transforming The Landscape Of Hpv Vaccines With The Launch Of Cervavac By Serum Institute Of India
Product innovations are a key trend gaining popularity in the human papillomavirus (HPV) vaccine market. Companies operating in the human papillomavirus (HPV) vaccine market are adopting new technologies to sustain their position in the market. For Instance, In January 2023, the Serum Institute of India, an India-based biotechnology and biopharmaceuticals company, launched CERVAVAC, the first quadrivalent Human Papillomavirus vaccine (qHPV) created entirely by Indian scientists. The Government of India intends to immunize girls between 9 and 14 against cervical cancer, making it an affordable and cost-effective vaccine.

The human papillomavirus (hpv) vaccine market covered in this report is segmented -

1) By Type: Tetravalent, Nonavalent, Bivalent
2) By Disease Indication: Cervical Cancer, Anal Cancer, Vulvar And Vaginal Cancer, Oropharyngeal Cancer, Other Indications
3) By Distribution Channel: Hospital And Retail Pharmacies, Government Suppliers, Other Channels
4) By Industry Vertical: Public And Private Alliance, Government Entities, Physicians, Other Industries

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12040&type=discount

Major companies operating in the human papillomavirus (hpv) vaccine market report are Johnson & Johnson Co, Merck & Co Inc., Novartis AG, Sanofi SA, GlaxoSmithKline Plc, AstraZeneca Pharma Ltd., Astellas Pharma Inc., CSL Limited, UCB SA, Serum Institute of India Pvt Ltd., Beijing Wantai Biological Pharmacy Enterprise Co Ltd., Emergent BioSolutions Inc., Bharat Biotech International Ltd., Walvax Biotechnology Co Ltd., Bavarian Nordic AS, Biofarma Co, Vaccitech Plc, Inovio Pharmaceuticals Inc., R-Pharm LLC, PathoVax LLC

Contents of the report:
1. Executive Summary
2. Human Papillomavirus (HPV) Vaccine Market Report Structure
3. Human Papillomavirus (HPV) Vaccine Market Trends And Strategies
4. Human Papillomavirus (HPV) Vaccine Market - Macro Economic Scenario
5. Human Papillomavirus (HPV) Vaccine Market Size And Growth
…..
27. Human Papillomavirus (HPV) Vaccine Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/human-papillomavirus-hpv-vaccine-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.